2005

研究業績

Papers (English)

Original papers

1. Chen W, Matsunari I, Noda A, Yanase D, Yajima K, Yamada M, Minoshima S, Nishimura S. A Rapid Scanning Protocol for Brain (18)F-FDG PET: A Validation Study. J Nucl Med 46:1633-1641, 2005

2. Furui E, Okamoto Y, Kida S, Yamashita J, Matsui O, Yamada M. Transient occlusion of the middle cerebral artery by macroembolism during carotid stenting for traumatic dissection of the common carotid artery. Circulation 112:33-34, 2005

3. Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura, Y,Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, Yamada M. Clinical diagnosis of MM2 type sporadic Creutzfeldt-Jakob disease. Neurology 64:643-648, 2005

4. Hamaguchi T, Okino S, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, Mizusawa H, Yamada M. Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 76:696-699, 2005

5. Hirohata M, Ono K, Naiki H, Yamada M. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer’s β-amyloid fibrils in vitro. Neuropharmacology 49:1088-1099, 2005

6. Hirohata M, Yasukawa Y, Ishida C, Komai K, Yamada M. Reversible cortical lesions in primary Sjogren’s syndrome presenting with meningoencephalitis as an initial manifestation. J Neurol Sci 232:111-113, 2005

7. Ishida C, Furui E, Sakashita Y, Yamada M. Embolic stroke with a patent foramen ovale and Behcet’s disease. Intern Med 44:326-327, 2005

8. Ishida C, Okino S, Kitamoto T, Yamada M. Involvement of the peripheral nervous system in human prion diseases including dural graft-associated Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 76:325-329, 2005

9. Kohno T, Tsuji T, Hirayama K, Iwatsuki R, Hirose M, Watabe K, Yoshikawa H, Kohno T, Matsumoto A, Fujita T, Hayashi M. A novel immunomodulator FTY720, prevents development of experimental autoimmune myasthenia gravis in C57BL/6 mice. Mol Pharm Bull 28:736-739, 2005

10. Konishi T, Yoshiyama Y, Takamori M, Saida T. Long-term treatment of generalized myasthenia gravis with FK506 (Taclorimus). J Neurol Neurosurg Psychiatry 76:448-450, 2005

11. McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard C, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM-Y, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. Dementia with Lewy Bodies: Diagnosis and Management: Third Report of the DLB Consortium. Neurology 65:1863-1872, 2005

12. Nemoto Y, Kuwabara S, Misawa S, Kawaguchi N, Hattori N, Takamori M, Vincent A. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychatry 76:714-718, 2005

13. Noguchi M, Yoshita M, Matsumoto Y, Ono K, Iwasa K, Yamada M. Decreased β-amyloid peptide42 in cerebrospinal fluiid of patients with progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 237:61-65, 2005

14. Noguchi M, Yoshita M, Sakai K, Matsumoto Y, Arahata M, Ontachi Y, Takami A, Nakao S,
Sato K, Yamada M. Peripheral neuropahty associated with chronic natural killer cell lymphocytosis. J Neurol Sci 232:119-122, 2005

15. Ono K, Hasegawa K, Naiki H, Yamada M. Preformed β-amyloid fibrils are destabilized by coenzyme Q10 in vitro. Biochem Biophys Res Commun 330:111-116, 2005

16. Ono K, Hirohata M, Yamada M. Ferulic acid destabilizes preformed β-amyloid fibrils in vitro. Biochem Biophys Res Commun 336:444-449, 2005

17. Ono K, Noguchi M, Matsumoto Y, Yanase D, Iwasa K, Naiki H, Yamada M. Cerebrospinal fluid of Alzheimer patients promotes β-amyloid fibril formation in vitro. Neurobiol Dis 20:233-240, 2005

18. Sakai K, Komai K, Yanase D, Yamada M. Plasma VEGF as a marker for the diagnosis and treatment of vasculitic neuropathy. J Neurol Neurosurg Psychiatry 76:296, 2005

19. Sakai K, Matsumoto Y, Kobayashi K, Yamada M. MRI of adult-onset type II citrullinemia. Intern Med 44:524-525, 2005

20. Samuraki M, Yoshita M, Yamada M. MRI of segmental zoster paresis. Neurology 64:1138, 2005

21. Takahashi K, Rochford DC, Neumann H. Clearance of apoptic neurons without inflammation by microglial TREM2. J Exp Med 201:647-659, 2005

22. Toru S, Yokota T, Tomimitsu H, Kanouchi T, Yamada M, Mizusawa H. Somatosensory-evoked cortical potential during attacks of paroxysmal dysesthesia in multiple sclerosis.Eur J Neurol 12:233-234, 2005

23. Yanase D, Matsunari I, Yajima K, Chen W, Fujikawa A, Nishimura S, Matsuda H, Yamada M. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol I maging 32:794-805, 2005

Reviews

1. Hirohata M, Yasukawa Y, Ishida C, Komai K, Yamada M : Reversible cortical lesions in primary Sj.gren’s syndrome presenting with meningoencephalitis as an initial manifestation. Review Series Rheumatology : The Schering-Plough Journal of Rheumatology. 7: 94-96, 2005

2. Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura, Y,Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M,
Yamada M：Clinical diagnosis of MM2 type sporadic Creutzfeldt-Jakob disease. Neurology 64:643-648, 2005

3. Yoshita M, Fletcher E, DeCarli C. Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging. Top Magn Reson Imaging 16:399-407, 2005

Book

1. Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura, Y,Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, Yamada M. MM2 type sporadic Creutzfeldt-Jakob disease: clinicoradologic features and clinical diagnosis. In: Kitamoto T, ed. Prions. Food and Drug Safety, Tokyo, Springer, pp241-243, 2005

2. Ishida C, Okino S, Kitamoto T, Yamada M. Involvement of the peripheral nervous system in human prion diseases including dural graft-associated Creutzfeldt-Jakob disease. In: Kitamoto T, ed. Prions. Food and Drug Safety, Tokyo, Springer, pp239-240, 2005

3. Saito Y, Murayama S, Shimizu J, Hoshino M, Takatsu M, Komatsusaki Y, Nakano S, Arima K, Sasaki K, Takahashi K, Hara M, Hirayasu Y, Yamada M, Kanazawa I. Familial Creutzfeldt-Jakob diseases with five octapeptide repeat insert. In: Kitamoto T, ed. Prions. Food and Drug Safety, Tokyo, Springer, pp249-250, 2005

4. Sato T, Masuda M, Utsumi Y, Enomoto Y, Yamada M, Mizusawa H, Kitamoto T. Dura mater related Creutzfeldt-Jakob disease in Japan: relationship between sites of grafts and clinical features. In: Kitamoto T, ed. Prions. Food and Drug Safety, Tokyo, Springer, pp31-40, 2005

5. Sodeyama N, Nakamura Y, Yamada M, Sato T, Kitamoto T, Mizusawa H. Duration between initial manifestation of CJD and detection of PSD, specific findings on MRI, CSF, 14-3-3- protein, or CSF high NSE. In: Kitamoto T, ed. Prions. Food and Drug Safety, Tokyo, Springer, pp235-236, 2005

6. Takamori M: Antibodies to muscle-specific tyrosine kinase and ryanodine receptor in myasthenia gravis. In:Giralt E, et al, ed. Current Topics in Peptide and protein Reserch. Trivandrum: Research Trends 2005

7. Takamori M: Myasthenia Gravis. In: Windhorst U, Binder M, Hirokawa N , ed : Encyclopedic Reference of Neuroscience. Heideberg (Germany): Springer-Verlag, 2005

Presentations (International meeting)

Invited lectures

1. Yamada M, Nakamura Y, Kawaguchi R. vCJD in Japan: European and Associated Countries Collaborative CJD Surveillance Group, May 5-7、2005、Stirling Highland Hotel, Stirling, Scotland

Presentations

1. Jha S, Xu KP, Wang H, Maruta T, Oshima M, Mosier DR, Atassi MZ. Antibodies against the muscle-specific kinase (MuSK) reduce the area of AChR clusters in a mouse model of myasthenia gravis. The Society for Neuroscience 35th Annual Meeting. Washington DC, November 12-16, 2005

2. Takahashi K, Rochford DC, Neumann H. Clearance of apoptotic neurons without inflammation by microglial TREM2. 30th G・ttingen Neurobiology Conference and 6th Meeting of the German Neuroscience Society G・ttingen, February 17-20, 2005

3. Takahashi K, Rochford DC, Neumann H. Involvement of microglial TREM2 in phagocytosis of apoptotic neurons without inflammation. 7th European Meeting on Glial Cell functions in Health and Disease Amsterdam, May 17-21, 2005

4. Yoshikawa H, Nakabayashi H, Yamada M. Prevalence of headache in students of Kanazawa University. XII Congress of the International Headache Society, Kyoto, Japan, October 9-12, 2005